NCT00140946
Completed
Phase 4
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Two-Period, Parallel-group Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients.
ConditionsAsthma
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Asthma
- Sponsor
- Organon and Co
- Enrollment
- 546
- Primary Endpoint
- Percentage of days of asthma exacerbations
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
A study to assess the clinical effect of montelukast sodium with concomitant administration of inhaled budesonide in asthmatic patients.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Males or females between the ages of 18 and 70 with asthma
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Percentage of days of asthma exacerbations
Secondary Outcomes
- Percentage of asthma free days
- Percentage of nocturnal awakenings
- Beta agonist use
Similar Trials
Completed
Phase 3
The Clinical Effect of MK0476 With Concomitant Administration of and Removal of Inhaled Beclomethasone in Asthmatic Patients (0476-029)AsthmaNCT00911547Organon and Co642
Completed
Phase 2
The Efficacy and Safety of Montelukast Sodium in the Prevention of Bronchopulmonary DysplasiaPremature BirthInfant, Very Low Birth WeightBronchopulmonary DysplasiaNCT01717625Ajou University School of Medicine72
Completed
Phase 3
A Pilot Study of Montelukast Sodium (Singulair) in Older Adults With Asthma or Chronic Obstructive Pulmonary DiseaseAsthmaCOPDNCT00162864Kaiser Permanente200
Completed
Phase 4
Asthma Control in Elderly Patients With MontelukastPersistent AsthmaElderlyNCT01147510Ajou University School of Medicine140
Completed
Phase 2
Study of Inhaled Corticosteroid Plus Montelukast Compared With Inhaled Corticosteroid Therapy Alone in Patients With Chronic Asthma (0476-386)AsthmaNCT00666679Organon and Co134